Cargando…
Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study
There is a notable lack of vaccine effectiveness studies using test-negative case-controlled approach in low- and middle-income countries which have different logistic, demographic and socio-economic conditions from high-income countries. We aimed to estimate the effectiveness of BNT162b2 vaccine ag...
Autores principales: | Lim, Audrey Huili, Ab Rahman, Norazida, Ong, Su Miin, Paraja, Jubaida, Rashid, Rahmah, Parmar, Ishvinder Singh, Dahlan, Siti Nadiah, Tan, Zhi Shan Sujata, Bohari, Ismuni, Peariasamy, Kalaiarasu M., Sivasampu, Sheamini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399819/ https://www.ncbi.nlm.nih.gov/pubmed/36030123 http://dx.doi.org/10.1016/j.vaccine.2022.08.032 |
Ejemplares similares
-
Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
por: Ab Rahman, Norazida, et al.
Publicado: (2023) -
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study
por: Ab Rahman, Norazida, et al.
Publicado: (2023) -
A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study Protocol
por: Ab Rahman, Norazida, et al.
Publicado: (2022) -
Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia
por: Husin, Masliyana, et al.
Publicado: (2022) -
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study
por: Ab Rahman, Norazida, et al.
Publicado: (2022)